Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,470,349
-
Share change
-
+2,708,340
-
Total reported value
-
$390,961,417
-
Put/Call ratio
-
92%
-
Price per share
-
$21.17
-
Number of holders
-
94
-
Value change
-
+$59,681,282
-
Number of buys
-
54
-
Number of sells
-
33
Institutional Holders of ADAMAS PHARMACEUTICALS INC - COM (ADMS) as of Q3 2017
As of 30 Sep 2017,
ADAMAS PHARMACEUTICALS INC - COM (ADMS) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,470,349 shares.
The largest 10 holders included
FMR LLC, Brenner West Capital Advisors, LP, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, RHENMAN & PARTNERS ASSET MANAGEMENT AB, Point72 Asset Management, L.P., CITADEL ADVISORS LLC, Kerrisdale Advisers, LLC, MACQUARIE GROUP LTD, and ARMISTICE CAPITAL, LLC.
This page lists
94
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.